Bill > LB762

This bill requires insurance policies, including individual and group sickness and accident insurance, and hospital, medical, or surgical expense policies, as well as self-funded employee benefit plans to the extent allowed by federal law, to cover treatments for two specific pediatric autoimmune disorders: "pediatric acute-onset neuropsychiatric syndrome," which refers to sudden behavioral changes in children and adolescents not explained by other medical issues, and "pediatric autoimmune neuropsychiatric disorder associated with a streptococcal infection," which is a condition where a strep infection causes abrupt or relapsing neuropsychiatric symptoms in children or adolescents. These covered treatments, which must be recommended by a licensed healthcare provider, can include antibiotics, medications, behavioral therapies, plasma exchange, and immunoglobulin. Additionally, insurance policies must report to the Department of Insurance annually, starting October 1, 2027, the number of times they denied coverage for these conditions and the specific treatments denied, and the department will then compile and publish this information on its website annually, starting December 1, 2028, to provide transparency on coverage denials. The bill also declares an emergency, meaning it will take effect immediately upon passage and approval.

Business and Industry

https://nebraskalegislature.gov/bills/view_bill.php?DocumentID=62636